Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReCAST AF: Flecainide vs Standard of Care in CAD and AF
NCT07405671Phase 4Recruiting
- Sponsor
- UZ Leuven
- Start
- Sep 2026
- Primary completion
- Dec 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of flecainide in Atrial fibrillation (AFib), sponsored by UZ Leuven. Started Sep 2026; status: recruiting.
02
Drugs
flecainide
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT07405671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07405671.